Angiogenesis is mainly driven by the proangiogenic cytokine VEGF, and elevated serum VEGF levels in NAFLD patients promote hepatic inflammation and fibrosis [37]. Here, VEGFA is linked to metabolic dysfunction-associated steatotic liver disease.